Scientific Congresses in Neuroscience

Selected Data Presentations

Select "Upcoming" to see a list of future scientific congresses in neuroscience. Select "Past" to review data and presentations from recent congresses. This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas.

Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling is left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.

Upcoming and Past Conferences

  • Upcoming

  • Past

American Epilepsy Society (AES), 2024

December 6 - 10, 2024 | Link to Event

Annual Meeting brings together healthcare providers, scientists, advocates, industry, and other professionals dedicated to better outcomes for people with epilepsy.

American Academy of Neurology (AAN), 2025

April 5 - 9, 2025 | Link to Event

Annual meeting in neurology promoting high quality patient-centric care in a variety of topics and specialties through various learning formats.

American Academy of Sleep Medicine (SLEEP), 2025

June 8 - 11, 2025 | Link to Event

Annual meeting of the Associated Professional Sleep Societies, LLC (APSS), which is a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).

U.S. Psychiatric and Mental Health Congress (US Psych), 2024

October 29 - November 2, 2024

National congress on practical psychopharmacology focused on practical, real-world training, covering the latest techniques, treatments, best practices, and evidence-based care.

Trintellix® (vortioxetine)

  • Antidepressant Changes and App Usage Improve MDD Outcomes in Study to Implement the Pathway Platform in Primary Care: A Post Hoc Subgroup Analysis
  • Noninterventional, Retrospective, Prospective, Longitudinal Cohort Study to Assess Antidepressant Treatment Patterns and Outcomes in Individuals With Major Depressive Disorder
  • Vortioxetine vs Standard of Care Antidepressants in Major Depressive Disorder: 24-Week Results From the PatientsLikeMe Observational Study (encore)

European College of Neuropsychopharmacology (ECNP), 2024

September 21 - 24, 2024

Europe's premier meeting in applied and translational neuroscience discussing the latest developments in research, technologies and treatment of brain disorders.

American Society of Clinical Psychopharmacology (ASCP), 2024

May 28 - 31, 2024

Annual meeting bringing perspectives together from academia, NIH, FDA, clinicians and industry on key aspects of neuropsychiatric drug development, pharmacogenetics and personalized interventions.

International College of Neuropsychopharmacology (CINP), 2024

May 23 - 26, 2024

Global annual congress offering a platform for learning about the latest research advances and new treatments in neuropharmacology, psychiatry, and neuroscience.

Professional Society for Health Economics and Outcomes Research (ISPOR), 2024

May 5 - 8, 2024

Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

American Psychiatric Association (APA), 2024

May 4 - 8, 2024

Annual meeting attracting the largest audience of psychiatrists and other mental health professionals offering opportunities to learn the latest in effective clinical practice, policy and research advancements.

American Academy of Neurology (AAN), 2024

April 13 - 18, 2024

Annual meeting in neurology promoting high quality patient-centric care in a variety of topics and specialties through various learning formats.

American Epilepsy Society (AES), 2023

December 1 - 5, 2023

Annual meeting bringing together healthcare professionals, scientists, advocates, industry representatives, and others who are working toward better outcomes for people with epilepsy.